Data / Research funding / Myasthenia Gravis
Myasthenia Gravis: 18 NIH awards ($22M) to 14 organizations
18 NIH awards ($22M) in the NIH spending category Myasthenia Gravis, to 14 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
18 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Targeted DOK7 gene therapy for Congenital Myasthenic Syndromes | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $4,856,116 | September 15, 2021 | August 31, 2026 | SEPULVEDA, PATRICIO | reporter.nih.gov |
| Manufacturing RNA-based CAR T cells to combat autoantibody-associated autoimmune disorders (AAAD) | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $2,992,236 | June 7, 2024 | May 31, 2026 | STEWART, CHARLES ANDREW | reporter.nih.gov |
| Mechanisms of autoimmunity in myasthenia gravis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,293,368 | November 4, 2015 | August 31, 2026 | O'CONNOR, KEVIN C | reporter.nih.gov |
| Structural mechanisms of autoimmune diseases targeting cys-loop receptors | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,890,985 | January 1, 2023 | December 31, 2027 | HIBBS, RYAN E | reporter.nih.gov |
| Wearable Sensor and Digital Technologies for Quantitative Assessment and Remote Monitoring of Symptoms in Myasthenia Gravis | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,514,629 | September 15, 2022 | November 30, 2026 | VAZIRI, ASHKAN | reporter.nih.gov |
| Targeted ColQ gene therapy for Congenital Myasthenic Syndromes | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,301,245 | June 1, 2023 | July 31, 2027 | SEPULVEDA, PATRICIO | reporter.nih.gov |
| Autologous T-cells Expressing a Chimeric Antigen Receptor Directed to B-Cell Maturation Antigen (BCMA) in patients with Generalized Myasthenia Gravis (MG) | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $1,154,358 | April 15, 2020 | March 31, 2022 | KURTOGLU, METIN | reporter.nih.gov |
| Mechanisms of neuromuscular junction formation | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,132,798 | July 1, 2013 | June 30, 2024 | XIONG, WEN-CHENG | reporter.nih.gov |
| Management of Blepharoptosis with Neodymium Magnet Systems: The Boston Blink-netic Project | NIH | National Eye Institute | 2021 to 2022 | $1,105,200 | September 30, 2018 | May 31, 2024 | HOUSTON, KEVIN EDWARD | reporter.nih.gov |
| Congenital Myasthenic Syndromes | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $887,698 | February 15, 2019 | January 31, 2024 | ENGEL, ANDREW GEORGE | reporter.nih.gov |
| Spatial Regulators of Skeletal Muscle Regeneration and Disease | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $738,702 | September 30, 2020 | February 28, 2026 | WANG, YU XIN | reporter.nih.gov |
| MV2C2 antibody as a new therapeutic for Myasthenia Gravis | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $463,979 | September 1, 2022 | August 31, 2024 | CIESIELSKI, MICHAEL J. | reporter.nih.gov |
| Molecular determinants driving diverse mechanisms of antibody-mediated pathology | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $460,625 | July 20, 2021 | June 30, 2024 | O'CONNOR, KEVIN C | reporter.nih.gov |
| Antigen-Specific Immunosuppression of Myasthenia Gravis by CAR-Engineered Tregs | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $451,716 | June 18, 2024 | October 31, 2025 | LUO, JIE | reporter.nih.gov |
| Identifying new antigens in human autoantibody-mediated disease | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $251,375 | September 2, 2025 | August 31, 2027 | O'CONNOR, KEVIN C | reporter.nih.gov |
| TASK ORDER 7 - DOK7 | NIH | National Institute on Drug Abuse | 2023 to 2024 | $238,533 | March 18, 2024 | March 17, 2025 | KOSOWSKY, AKIVA | reporter.nih.gov |
| Engineering of a mouse model of choline acetycholinesterase deficients using CRISPR/Cas9 gene editing | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $159,750 | July 1, 2022 | June 30, 2024 | MASELLI, RICARDO ANIBAL | reporter.nih.gov |
| Spatial Regulators of Skeletal Muscle Regeneration and Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $88,722 | September 30, 2020 | August 31, 2022 | WANG, YU XIN | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| Amplo Biotechnology, Inc. | Towson, MD | 2 | $6.2 million | 0 | $0 |
| Cartesian Therapeutics, Inc. | Gaithersburg, MD | 2 | $4.1 million | 0 | $0 |
| Yale University | New Haven, CT | 3 | $3 million | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 1 | $1.9 million | 0 | $0 |
| Biosensics, LLC | Newton, MA | 1 | $1.5 million | 0 | $0 |
| Case Western Reserve University | Cleveland, OH | 1 | $1.1 million | 0 | $0 |
| Massachusetts Eye and Ear Infirmary | Boston, MA | 1 | $1.1 million | 0 | $0 |
| Mayo Clinic Rochester | Rochester, MN | 1 | $887,698 | 0 | $0 |
| Sanford Burnham Prebys Medical Discovery Institute | La Jolla, CA | 1 | $738,702 | 0 | $0 |
| Mimivax, LLC | Buffalo, NY | 1 | $463,979 | 0 | $0 |
| George Washington University | Washington, DC | 1 | $451,716 | 0 | $0 |
| A and G Pharmaceutical, Inc. | Columbia, MD | 1 | $238,533 | 0 | $0 |
| University of California at Davis | Davis, CA | 1 | $159,750 | 0 | $0 |
| Stanford University | Stanford, CA | 1 | $88,722 | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 8 | $5,222,418 | 0 | $0 |
| 2024 | 7 | $5,910,415 | 0 | $0 |
| 2023 | 7 | $2,188,508 | 0 | $0 |
| 2022 | 9 | $4,854,661 | 0 | $0 |
| 2021 | 8 | $3,806,033 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.